EdwardRileyMD

Anesthesiology • Stanford, CA

Obstetrical Anesthesiology

Professor, Anesthesiology, Stanford University Medical Center

Join to view full profile

Dr. Riley is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Riley's full profile

Already have an account?

Office
300 Pasteur Dr
Stanford, CA 94305
Phone+1 650-498-5710

Fax+1 650-498-5840

Education & Training

Legacy Health/Emanuel Medical CenterInternship, Internal Medicine, 1989 - 1990
University of Washington School of MedicineClass of 1989

Certifications & Licensure

CA State Medical License 1991 - 2025
WA State Medical License 2016 - 2017
American Board of Anesthesiology Anesthesiology

Clinical Trials

PIEB vs CEI for Labor Analgesia: An MLAC Study Start of enrollment: 2015 Oct 01
Terminated
Phase 4
Roles: Contact

Publications & Presentations

PubMed

62 citations
The site of action of epidural fentanyl in humans: the difference between infusion and bolus administration.
Y. Ginosar, Edward T. Riley, Martin S. Angst
Anesthesia and Analgesia. 2003-11-01
4 citations
Calcium chloride for the prevention of uterine atony during cesarean delivery: A pilot randomized controlled trial and pharmacokinetic study.
Jessica R Ansari, Neil Kalariya, Brendan Carvalho, Pamela Flood, Nan Guo
Journal of Clinical Anesthesia. 2022-09-01
18 citations
Minimum effective bolus dose of oxytocin during elective Caesarean delivery.
A J Butwick, L Coleman, S E Cohen, E T Riley, B Carvalho
British Journal of Anaesthesia. 2010-03-01

Authored Content

Voices in the OR: A Self-Reflection and Examination of Unconscious BiasOctober 2020

Press Mentions

EpiFaith® Expanding to U.S. Military Hospitals After a Newly Awarded Agreement by the Defense Logistics AgencyJune 29th, 2021
The Safe Epidural Protector, EpiFaith®, Announced FDA 510(K) Clearance and Global Launch TimelineMay 17th, 2019
Having Fully Stocked Cart to Treat Malignant Hyperthermia During Labor Not Cost-BeneficialApril 18th, 2018